Dr Rafal G Ciecierski, MD - Medicare Hospitalist in Appleton, WI

Dr Rafal G Ciecierski, MD is a medicare enrolled "Hospitalist" physician in Appleton, Wisconsin. He graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Hospitalist. He is a member of the group practice Ascension Medical Group-fox Valley Wisconsin Inc, Beloit Health System Inc, St Vincent Hospital-hospital Sisters-third Order Of St Francis, Lafayette Kidney Care Llc, Hawaii Nephrologists Llc and his current practice location is 1818 N Meade St, Appleton, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (920) 735-7645.

Dr Rafal G Ciecierski is licensed to practice in Wisconsin (license number 53317) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1093916595.

Contact Information

Dr Rafal G Ciecierski, MD
1818 N Meade St,
Appleton, WI 54911-3454
(920) 735-7645
(920) 735-7618



Physician's Profile

Full NameDr Rafal G Ciecierski
GenderMale
SpecialityHospitalist
Experience26 Years
Location1818 N Meade St, Appleton, Wisconsin
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Rafal G Ciecierski graduated from medical school in 1998
  NPI Data:
  • NPI Number: 1093916595
  • Provider Enumeration Date: 05/30/2007
  • Last Update Date: 06/21/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2163577586
  • Enrollment ID: I20090908000264

Medical Identifiers

Medical identifiers for Dr Rafal G Ciecierski such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093916595NPI-NPPES
100005162MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 53317 (Wisconsin)Primary
208M00000XHospitalist 036122585 (Illinois)Secondary
207R00000XInternal Medicine 036122585 (Illinois)Secondary
207RN0300XInternal Medicine - Nephrology 53317 (Wisconsin)Secondary
207RN0300XInternal Medicine - Nephrology 036122585 (Illinois)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Christus St Frances Cabrini HospitalAlexandria, LAHospital
The Queens Medical CenterHonolulu, HIHospital
Rapides Regional Medical CenterAlexandria, LAHospital
Pali Momi Medical CenterAiea, HIHospital
Beloit Health SystemBeloit, WIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Ascension Medical Group-fox Valley Wisconsin Inc0244142420258
Beloit Health System Inc8224947858110
St Vincent Hospital-hospital Sisters-third Order Of St Francis5799694675562
Lafayette Kidney Care Llc40829872358
Hawaii Nephrologists Llc670900742010

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Rafal G Ciecierski allows following entities to bill medicare on his behalf.
Entity NameAscension Medical Group-fox Valley Wisconsin Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730126392
PECOS PAC ID: 0244142420
Enrollment ID: O20031105000351

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NamePrevea Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306869276
PECOS PAC ID: 0042123150
Enrollment ID: O20031106000034

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameMercy Health System Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598718603
PECOS PAC ID: 7416860440
Enrollment ID: O20031113000164

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameAspirus Rhinelander & Tomahawk Hospitals & Clinics Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144991340
PECOS PAC ID: 9335059856
Enrollment ID: O20031126000706

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameBeloit Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568677417
PECOS PAC ID: 8224947858
Enrollment ID: O20031215000424

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameAspirus Wausau Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922321140
PECOS PAC ID: 6406757442
Enrollment ID: O20040114000297

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameSt. Nicholas Hospital-sisters Of The Third Order Of St Francis
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275799413
PECOS PAC ID: 8325931652
Enrollment ID: O20040202001172

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameHoward Young Medical Center Inc Of Woodruff Wisconsin
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184673352
PECOS PAC ID: 4183519606
Enrollment ID: O20040419000970

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameAscension Calumet Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376541748
PECOS PAC ID: 7416948427
Enrollment ID: O20040809000191

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameSt Clare Memorial Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851477913
PECOS PAC ID: 0446211395
Enrollment ID: O20041023000037

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameAscension Ne Wisconsin, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407803638
PECOS PAC ID: 7719897784
Enrollment ID: O20061027000037

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Entity NameSt Vincent Hospital-hospital Sisters-third Order Of St Francis
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285613638
PECOS PAC ID: 5799694675
Enrollment ID: O20080620000423

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rafal G Ciecierski is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Rafal G Ciecierski, MD
W4209 Jennie Lee Ct,
Malone, WI 53049-1717

Ph: () -
Dr Rafal G Ciecierski, MD
1818 N Meade St,
Appleton, WI 54911-3454

Ph: (920) 735-7645

News Archive

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities.

Vanderbilt researchers receives new $2.1M grant to develop microbrain bioreactor

Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.

Update on microdosing

One of yesterday's most promising new tools for speeding the development of new medicines - "microdosing" - has found niches in that process today, and they include uses unanticipated a decade ago.

Read more News

› Verified 2 days ago


Hospitalist Doctors in Appleton, WI

Bessant A Parker, MD
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 1506 S Oneida St, Hospital Service Department, Appleton, WI 54915
Phone: 920-738-2000    
Matthew Boese,
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 920-735-7645    Fax: 920-735-7618
Aimee C Morell-watton, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 920-735-7645    Fax: 920-735-7618
Lulseged Zenebe, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1506 S Oneida St, Hospital Service, Appleton, WI 54915
Phone: 920-738-2000    
Suranga Mihindu Dharmaratne, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 920-735-7645    Fax: 920-735-7618
Arshad Al-mashhadani, MD
Hospitalist
Medicare: May Accept Medicare Assignments
Practice Location: 1818 N Meade St, Appleton, WI 54911
Phone: 920-735-7645    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.